ELVN icon

Enliven Therapeutics
ELVN

17 hedge funds and large institutions have $174M invested in Enliven Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$64.4M
2
+$43.6M
3
+$23.3M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.2M
5
DM
Deerfield Management
New York
+$8.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$64.4M
2
$43.6M
3
$23.3M
4
$17.2M
5
$8.02M
6
$7.15M
7
$4.12M
8
$2.31M
9
$1.12M
10
$769K
11
$641K
12
$599K
13
$509K
14
$318K
15
$106K
16
$31K
17
$16K